bosentan anhydrous has been researched along with vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gopalakrishnan, V; McNeill, JR; Yu, M | 1 |
1 other study(ies) available for bosentan anhydrous and vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-
| Article | Year |
|---|---|
Role of endothelin and vasopressin in DOCA-salt hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Bosentan; Cardiac Output; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertension; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Vascular Resistance; Vasopressins | 2001 |